Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MALACHITE INNOVATIONS, INC.

(MLCT)
 SummaryQuotesChartsNewsCompanyFinancials 
Quotes 5-day view   Delayed Quote. Delayed Otc Markets
10/18/2021 10/19/2021 10/20/2021 10/21/2021 10/22/2021 Date
0.35(c) 0.36(c) 0.3395(c) 0.36(c) 0.39(c) Last
5 175 6 380 17 119 48 881 43 911 Volume
+20.65% +2.86% -5.69% +6.04% +8.33% Change
More quotes
Estimated financial data (e) (USD)
Sales 2020 - - -
Net income 2020 -4,37 M - -
Net cash position 2020 2,27 M - -
P/E ratio 2020 -0,35x
Yield 2020 -
Sales 2021 - - -
Net income 2021 -0,88 M - -
Net cash position 2021 0,85 M - -
P/E ratio 2021 -10,4x
Yield 2021 -
Capitalization 20,0 M 20,0 M -
EV / Sales 2020 -
EV / Sales 2021 -
Nbr of Employees 3
Free-Float 66,4%
More Financials
Company
Malachite Innovations, Inc, formerly Vitality Biopharma, Inc., is a biopharmaceutical company. The Company is focused on developing the cannabinoid pharmaceutical prodrugs also known as cannabosides. The Company utilizes its enzymatic bioprocessing technologies to discover its cannabosides are cannabinoid-glycoside prodrugs. The Company’s cannabosides products include glycosylated tetrahydrocannabinol (THC),... 
More about the company
All news about MALACHITE INNOVATIONS, INC.
10/12VITALITY BIOPHARMA : ADOPTS NEW NAME – MALACHITE INNOVATIONS, INC - Form 8-K
PU
10/12VITALITY BIOPHARMA, INC. : Entry into a Material Definitive Agreement, Amendments to Artic..
AQ
10/12VITALITY BIOPHARMA : Adopts New Name – Malachite Innovations, Inc.
GL
10/12Malachite Innovations, Inc. Announces Change of Corporate Headquarters
CI
10/12Malachite Innovations, Inc. Announces Fiscal Year Change
CI
10/12Malachite Innovations, Inc. has Changed its Ticker to MLCT from VBIO
CI
09/02Vitality Biopharma Announces Effective S-1 Registration Statement and DTC Eligibility
GL
09/02VITALITY BIOPHARMA : ANNOUNCES EFFECTIVE S-1 REGISTRATION STATEMENT AND DTC ELIGIBILITY (F..
PU
09/02VITALITY BIOPHARMA, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
08/23VITALITY BIOPHARMA : Enters into $5 million equity financing relationship with institution..
AQ
08/20VITALITY BIOPHARMA : ENTERS INTO $5 MILLION EQUITY LINE FINANCING RELATIONSHIP WITH INSTIT..
PU
08/20VITALITY BIOPHARMA, INC. : Entry into a Material Definitive Agreement, Other Events, Finan..
AQ
08/20Vitality Biopharma Enters Into $5 Million Equity Line Financing Relationship With Insti..
GL
08/19Vitality Biopharma, Inc. announced that it expects to receive $5 million in funding
CI
08/13VITALITY BIOPHARMA : Management's Discussion and Analysis of Financial Condition and Resul..
AQ
More news
News in other languages on MALACHITE INNOVATIONS, INC.

- No features available -

More news
Chart MALACHITE INNOVATIONS, INC.
Duration : Period :
Malachite Innovations, Inc. Technical Analysis Chart | MLCT | US56089M1071 | MarketScreener
Income Statement Evolution
Managers and Directors
Michael Cavanaugh Chief Executive Officer & Director
Richard McKilligan Controller, Chief Financial & Accounting Officer
Edward F. Feighan Executive Chairman
Brandon Zipp Chief Science Officer
Richard F. Celeste Independent Director
Sector and Competitors
1st jan.Capi. (M$)
MALACHITE INNOVATIONS, INC.550.00%20
GILEAD SCIENCES, INC.15.41%84 306
BIONTECH SE241.44%67 225
WUXI APPTEC CO., LTD.24.51%64 578
REGENERON PHARMACEUTICALS18.47%59 507
VERTEX PHARMACEUTICALS-22.35%47 610